review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Tesshi Yamada | Q88326275 |
Setsuo Hirohashi | Q116761102 | ||
P2093 | author name string | Miki Shitashige | |
P2860 | cites work | Cellular roles of dna topoisomerases: a molecular perspective | Q22121990 |
Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling | Q24295533 | ||
The Krüppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway | Q24296279 | ||
The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus | Q24297804 | ||
Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex | Q24299664 | ||
Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway | Q24300418 | ||
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma | Q24304506 | ||
Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development | Q24307491 | ||
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma | Q24309359 | ||
Identification of c-MYC as a target of the APC pathway | Q24310637 | ||
Physiological and functional interactions between Tcf4 and Daxx in colon cancer cells | Q24311467 | ||
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells | Q24314491 | ||
Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo | Q24319343 | ||
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | Q24336272 | ||
Cancer genetics: colorectal cancer as a model. | Q36441076 | ||
Differential binding of heterogeneous nuclear ribonucleoproteins to mRNA precursors prior to spliceosome assembly in vitro | Q36819376 | ||
PolyADP-ribosylation and cancer | Q36889328 | ||
Increased susceptibility of Sf1(+/-) mice to azoxymethane-induced colon tumorigenesis | Q38297807 | ||
Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent | Q40141842 | ||
Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. | Q40154769 | ||
RanBP3 enhances nuclear export of active (beta)-catenin independently of CRM1. | Q40346466 | ||
Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | Q40361099 | ||
Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression | Q40443907 | ||
Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma | Q40651937 | ||
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors | Q40949632 | ||
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer | Q42794991 | ||
PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter | Q45280595 | ||
The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. | Q50336935 | ||
Function of poly(ADP-ribose) polymerase in response to DNA damage: gene-disruption study in mice. | Q52535087 | ||
Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. | Q52566206 | ||
Drosophila Tcf and Groucho interact to repress Wingless signalling activity. | Q52566295 | ||
Mediator is a transducer of Wnt/beta-catenin signaling. | Q52569557 | ||
Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells. | Q53585440 | ||
Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex. | Q54660344 | ||
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies | Q24337920 | ||
The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation | Q24534469 | ||
Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1 | Q24535621 | ||
Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex | Q24563333 | ||
Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity | Q24597019 | ||
PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies | Q24599898 | ||
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways | Q24647244 | ||
Sumoylation is involved in beta-catenin-dependent activation of Tcf-4 | Q24675969 | ||
HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells | Q24678212 | ||
Structural basis for recognition of the intron branch site RNA by splicing factor 1 | Q27635949 | ||
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells | Q27860717 | ||
Lessons from hereditary colorectal cancer | Q28131788 | ||
Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development | Q28216579 | ||
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS | Q28262912 | ||
Functional interaction of beta-catenin with the transcription factor LEF-1 | Q28286884 | ||
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 | Q28592260 | ||
The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression | Q28640562 | ||
Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway | Q28640887 | ||
Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF | Q28645084 | ||
Nuclear localization of beta-catenin by interaction with transcription factor LEF-1 | Q29614379 | ||
Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus | Q29620188 | ||
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex | Q31038919 | ||
A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected] | Q31106002 | ||
Wnt breakers in colon cancer | Q33197185 | ||
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors | Q33952813 | ||
The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates | Q34486253 | ||
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas | Q35004950 | ||
Tumor formation by genetic mutations in the components of the Wnt signaling pathway | Q35161748 | ||
Epigenetic changes in colorectal cancer. | Q35682096 | ||
Inactivation of the E-cadherin-mediated cell adhesion system in human cancers | Q35753235 | ||
Regulation of beta -catenin transformation by the p300 transcriptional coactivator. | Q35819973 | ||
Etoposide: discovery and medicinal chemistry | Q35893003 | ||
P433 | issue | 4 | |
P304 | page(s) | 631-637 | |
P577 | publication date | 2008-01-02 | |
P1433 | published in | Cancer Science | Q326125 |
P1476 | title | Wnt signaling inside the nucleus | |
P478 | volume | 99 |
Q41367937 | A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. |
Q33778033 | Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis |
Q39969056 | Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation |
Q35863203 | Altering cancer transcriptomes using epigenomic inhibitors |
Q53211105 | Alternative splicing within the Wnt signaling pathway: role in cancer development. |
Q33907839 | Brain metastases from lung cancer show increased expression of DVL1, DVL3 and beta-catenin and down-regulation of E-cadherin |
Q42176198 | Ca2+/calmodulin‐stimulated PDE1 regulates the beta‐catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells |
Q59798121 | Cancer Stem Cells: Emergent Nature of Tumor Emergency |
Q36378040 | Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3. |
Q26801596 | Chronic inflammation and the development of malignancy in the GI tract |
Q37438687 | Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1. |
Q26865911 | Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk |
Q37966605 | Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers |
Q35530296 | Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodies |
Q45954140 | Going with the Wnt? Focus on "Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC". |
Q24312550 | Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression |
Q57468706 | HPV-18 E6 Oncoprotein and Its Spliced Isoform E6*I Regulate the Wnt/β-Catenin Cell Signaling Pathway through the TCF-4 Transcriptional Factor |
Q52374120 | Human Gut Microbiota and Gastrointestinal Cancer. |
Q41090566 | IL-6 variant is associated with metastasis in breast cancer patients. |
Q37260274 | Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients |
Q38722382 | Inference of hierarchical regulatory network of TCF7L2 binding sites in MCF7 cell line |
Q33560729 | Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth |
Q28481465 | Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway |
Q41904328 | Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis |
Q35930474 | MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways |
Q37793987 | Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes |
Q30442237 | Neurodevelopment in schizophrenia: the role of the wnt pathways |
Q39627462 | PKM2: a new player in the β-catenin game |
Q37998994 | Rho GTPase signaling in the development of colorectal cancer |
Q43242602 | Stem cells might participate in the cell turnover of duodenal adenomas. |
Q34720607 | T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis |
Q39733618 | TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling |
Q37223261 | TNIK inhibition abrogates colorectal cancer stemness |
Q34555251 | Targeting stem cells-clinical implications for cancer therapy |
Q34516725 | The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy |
Q47303572 | The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation. |
Q52782861 | The emergence of TNIK as a therapeutic target for colorectal cancer. |
Q37919693 | The regulation of valvular and vascular sclerosis by osteogenic morphogens |
Q34880355 | The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. |
Q34074375 | Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation |
Q33959150 | Upregulation of SPRR3 promotes colorectal tumorigenesis |
Q28303536 | Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone |
Q39637423 | Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation |
Q34055717 | miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. |
Q37699951 | miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/β-Catenin Pathway in Tongue Squamous Cell Carcinoma. |
Q90616207 | β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice |
Q36144844 | β-Catenin recognizes a specific RNA motif in the cyclooxygenase-2 mRNA 3'-UTR and interacts with HuR in colon cancer cells |
Q24299284 | β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells |